INC Research Launches Women’s Health Division
Multi-Therapeutic Team Will Focus on Unique Drug Development Issues
in Women
RALEIGH, N.C. (Business Wire EON/PRWEB ) May 29, 2008 --
INC Research ®,
Inc., a therapeutically-focused contract research organization (CRO)
with a process for delivering reliable results, today announced the
launch of its Women’s
Health Division. Leading the group will be Cynthia Madden, MD, MPH.
The division will be a premier provider of multi-therapeutic women’s
health drug development services.
Dr. Madden has worked for the FDA in the Division of Investigational New
Drugs, and received additional training at the National Institutes of
Health. She completed a Robert Wood Johnson Clinical Scholars Fellowship
and holds a Masters of Public Health degree in clinical epidemiology.
Dr. Madden is board certified in emergency medicine, and completed an
additional residency in preventive medicine. With broad experience
across specialties in clinical medicine, including teaching, research
and administration, Dr. Madden understands women’s
special health concerns.
“Dr. Madden has 19 years of direct clinical
care experience, focusing on women's health issues and has developed a
distinctive acumen for the complex underlying medical, recruitment and
retention issues which so dramatically impact the success of clinical
trials in women,” states John Potthoff, chief
operating officer of INC Research. “By
utilizing our Trusted Process methodology, INC Research has already
developed a solid reputation for the successful conduct of clinical
trials in women’s health such as breast cancer
trials in our Oncology Division and fibromyalgia trials in our CNS
Division. In order to further enhance our global service offering in
response to customer demand, Dr. Madden and her experienced team are now
organized to develop solutions and deploy best practices to manage
programs addressing women's unique health needs. Their specialized
expertise is a huge value-add for our customers.”
Dr. Madden adds, “The Women’s
Health Division at INC Research combines clinical expertise in the
diseases that most affect women, with an understanding of the challenges
our customers face in developing drugs for this population that must
factor in gender and age nuances. Our team takes a highly collaborative
approach to understand and plan for those challenges in order to
successfully execute all phases of a clinical trial and a clinical
development program. I am very excited to be leading this innovative,
nimble team.”
About INC Research®
Inc.
INC Research is a therapeutically-focused contract research organization
with a high performance reputation for conducting global clinical
development programs of the highest integrity. Pharmaceutical and
biotechnology companies look to INC Research for a complete range of
customized Phase I through Phase IV programs in therapeutic areas of
specialty, and in innovative pediatric and women’s
health trials. The company’s “The
Trusted Process®”
methodology and therapeutic foresight leads customers to more confident,
better-informed drug and device development decisions. INC Research is
headquartered in Raleigh, North Carolina, with 25 office locations and a
presence in 32 countries worldwide. For more information please visit www.incresearch.com.
See the original story at: http://eon.businesswire.com/releases/research/health/prweb981784.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1TaW5nLUhvcnItUHJvZi1DcmFzLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
